Delphine Vimont
Scientific articles
- 
                              
                    N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake
 J. Med. Chem.. 2025-03-20. 68(7) : 7280-7290.
 10.1021/acs.jmedchem.4c02844
- 
                              
                    Design and Synthesis of 68Ga‐Labeled Peptide‐Based Heterodimers for Dual Targeting of NTS1 and GRPR
 ChemMedChem. 2025-02-16.
 10.1002/cmdc.202400843
- 
                              
                    Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics
 RSC Med. Chem.. 2024-01-01. 15(12) : 4153-4158.
 10.1039/d4md00491d
- 
                              
                    Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R
 Cancers. 2023-04-18. 15(8) : 2345.
 10.3390/cancers15082345
- 
                              
                    Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2
 ACS Omega. 2023-02-10. 8(7) : 6994-7004.
 10.1021/acsomega.2c07814
- 
                              
                    Comparison of 68Ga-PSMA-617 PET/CT and 68Ga-RM2 PET/CT in patients with localized prostate cancer candidate for radical prostatectomy: a prospective, single arm, single center, phase II study
 J Nucl Med. 2022-09-02. : jnumed.122.263889.
 10.2967/jnumed.122.263889
- 
                              
                    In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease.
 EJNMMI Res. 2021-05-05. 11(1)
 10.1186/s13550-021-00786-7
- 
                              
                    Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS1-Positive Tumors Imaging
 Bioconjugate Chem.. 2020-09-18.
 10.1021/acs.bioconjchem.0c00419
- 
                              
                    Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides
 EJNMMI Res. 2020-03-02. 10(1)
 10.1186/s13550-020-0612-8
- 
                              
                    Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples
 EJNMMI Res. 2019-06-03. 9(1)
 10.1186/s13550-019-0517-6
